Abstract
Natural products have been an important historical source of therapeutic agents. Microorganisms are major source of bioactive natural products, and several microbial products including antibiotics, anti-inflammatory, anti-tumour, immunosuppressants and others are currently used as therapeutic agents for human and domestic animals. Most of these products were obtained from cultured environmental microorganisms. However, it is widely accepted that a very large majority of the microorganisms present in natural environments are not readily cultured under laboratory conditions, and therefore are not accessible for drug discovery. Metagenomics is a recent culture-independent approach that has been developed to access the collective genomes of natural bacterial populations. It enables discovery of the diverse biosynthetic pathways encoded by diverse microbial assemblages that are known to be present in the environment but not-yet cultured. Recently, several new bioactive molecules and proteins have been discovered using a metagenomic approach. This review highlights the recent methodologies, limitations, and applications of metagenomics for the discovery of new drugs. Moreover, it shows how a multidisciplinary approach combining metagenomics with other technologies can expedite and revolutionize drug discovery from diverse environmental microorganisms. Key words: Microbial diversity, metagenomics, natural products, drug discovery, microbial ecology
Highlights
Tapping uncultured microorganisms through metagenomics for drug discoveryAbdelnasser Salah Shebl Ibrahim*, Ali Abdullah Al-Salamah, Ashraf A
Microorganisms are major source of bioactive natural products, and several microbial products including antibiotics, antiinflammatory, anti-tumour, immunosuppressants and others are currently used as therapeutic agents for human and domestic animals
The advent of high throughput screening (HTS) and the availability of combinatorial compound libraries has led to a decline in the emphasis on natural products by the major pharmaceutical companies over the past decade (Rouhi, 2003; Gullo et al, 2005)
Summary
Abdelnasser Salah Shebl Ibrahim*, Ali Abdullah Al-Salamah, Ashraf A. Microorganisms are major source of bioactive natural products, and several microbial products including antibiotics, antiinflammatory, anti-tumour, immunosuppressants and others are currently used as therapeutic agents for human and domestic animals. Most of these products were obtained from cultured environmental microorganisms. Metagenomics is a recent culture-independent approach that has been developed to access the collective genomes of natural bacterial populations It enables discovery of the diverse biosynthetic pathways encoded by diverse microbial assemblages that are known to be present in the environment but not-yet cultured.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
